71 related articles for article (PubMed ID: 8242419)
1. [Membrane receptors and coupling proteins in adenohypophyseal cells].
Cussac D; Caccavelli L; Pellegrini I; Audinot V; Jaquet P; Enjalbert A
C R Seances Soc Biol Fil; 1993; 187(1):14-23. PubMed ID: 8242419
[TBL] [Abstract][Full Text] [Related]
2. D2 dopaminergic receptors: normal and abnormal transduction mechanisms.
Caccavelli L; Cussac D; Pellegrini I; Audinot V; Jaquet P; Enjalbert A
Horm Res; 1992; 38(1-2):78-83. PubMed ID: 1306522
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
O'Hara CM; Tang L; Taussig R; Todd RD; O'Malley KL
J Pharmacol Exp Ther; 1996 Jul; 278(1):354-60. PubMed ID: 8764370
[TBL] [Abstract][Full Text] [Related]
4. Expression and pharmacological characterization of the human D3 dopamine receptor.
Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G
J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582
[TBL] [Abstract][Full Text] [Related]
5. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
Chio CL; Lajiness ME; Huff RM
Mol Pharmacol; 1994 Jan; 45(1):51-60. PubMed ID: 8302280
[TBL] [Abstract][Full Text] [Related]
6. SH3 binding domains in the dopamine D4 receptor.
Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
[TBL] [Abstract][Full Text] [Related]
7. D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69.
Senogles SE
Anticancer Drugs; 2007 Aug; 18(7):801-7. PubMed ID: 17581302
[TBL] [Abstract][Full Text] [Related]
8. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells.
Boundy VA; Lu L; Molinoff PB
J Pharmacol Exp Ther; 1996 Feb; 276(2):784-94. PubMed ID: 8632351
[TBL] [Abstract][Full Text] [Related]
9. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.
Wang S; Hashemi T; Fried S; Clemmons AL; Hawes BE
Biochemistry; 1998 May; 37(19):6711-7. PubMed ID: 9578554
[TBL] [Abstract][Full Text] [Related]
10. Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines.
Kuzhikandathil EV; Yu W; Oxford GS
Mol Cell Neurosci; 1998 Dec; 12(6):390-402. PubMed ID: 9888991
[TBL] [Abstract][Full Text] [Related]
11. Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
Castellano MA; Liu LX; Monsma FJ; Sibley DR; Kapatos G; Chiodo LA
Mol Pharmacol; 1993 Sep; 44(3):649-56. PubMed ID: 8371717
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
Vortherms TA; Watts VJ
J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
[TBL] [Abstract][Full Text] [Related]
13. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
14. Chimeric dopamine D2/angiotensin AT1 receptors: role of the length of third intracellular loop of D2 receptors in conferring specificity of receptor binding and G-protein coupling.
Chen H; Zhang YY; Han QD
Zhongguo Yao Li Xue Bao; 1997 May; 18(3):209-13. PubMed ID: 10072934
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity.
Ghavami A; Hunt RA; Olsen MA; Zhang J; Smith DL; Kalgaonkar S; Rahman Z; Young KH
Cell Signal; 2004 Jun; 16(6):711-21. PubMed ID: 15093612
[TBL] [Abstract][Full Text] [Related]
16. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
[TBL] [Abstract][Full Text] [Related]
17. D2 dopamine receptor activation of potassium channels is selectively decoupled by Galpha-specific GoLoco motif peptides.
Webb CK; McCudden CR; Willard FS; Kimple RJ; Siderovski DP; Oxford GS
J Neurochem; 2005 Mar; 92(6):1408-18. PubMed ID: 15748159
[TBL] [Abstract][Full Text] [Related]
18. Novel regulatory properties of human type 9 adenylate cyclase.
Cumbay MG; Watts VJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):108-15. PubMed ID: 14996950
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 proteins in rat anterior pituitary cell membranes.
Rasolonjanahary R; Gerard C; Dufour MN; Homburger V; Enjalbert A; Guillon G
Endocrinology; 2002 Mar; 143(3):747-54. PubMed ID: 11861492
[TBL] [Abstract][Full Text] [Related]
20. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
